About our fillers

Product of the month

About our devices

Product of the month

SECTUM

Synergistic approach

CLINICALLY PROVEN SUPERIOR RESULTS

Age-related anatomical changes are most effectively managed through the combination of science and technology.

To achieve this goal and by applying the knowledge developed over the years, Neauvia research designed SMART COMBINATION THERAPY – SCT.

SCT is an innovative synergistic approach, supported by science and clinical research, which consists of a comprehensive system of protocols combining different treatments and delivering optimal results. ^{1, 2}

By offering a different perspective on medical aesthetic treatments, Neauvia set new trends.

skin REGENERATION

The appearance of the face typically changes with age. The skin loses elasticity and becomes thinner, less oily and more vulnerable to the sun’s harmful UV rays. The body produces less collagen, elastin, and hyaluronic acid. Facial muscles, ligaments and bones suffer a loss of tone. Skin aging is thus a physiological and progressive multi-factor phenomenon, involving several anatomical layers and requiring a combination of therapies to be slowed down.

To help skin regeneration, then,Neauvia introduced NLIFT – the MID-FACE SYNERGISTIC PROTOCOL – treating different skin layers by combining Dermal Fillers, Waterpeeling, Infrared Thermo Lifting and Aesthetic Cosmeceuticals.

Discover Nlift

epidermis RESTORING

As the outermost layer of the skin, the epidermis plays a key role in protecting the body from the harmful effects of external factors and in limiting water loss. The ageing process, sun exposure and/or hormonal disorders directly affect the proper functioning of the epidermis, making it thinner, rough and dry. When the skin’s natural barrier is weak, its protective function and healthy appearance are compromised.

To keep the epidermis in good condition and prevent the first signs of ageing, Neauvia developed NBOOST the EPIDERMIS RESTORING SYNERGISTIC PROTOCOL, combining Radio Frequency, Linear HA Filler and Aesthetic Cosmeceuticals.

Discover Nboost

intimate WELL-BEING

As for any other part of the body, the vaginal mucosa and the female genital region age and are vulnerable to several factors of change such as hormonal changes, pregnancy and menopause, weight variations and intensive sport. Some resulting intimate concerns as sagging, loss of firmness, accompanying irritation or frequent infections, sensation of pleasure decrease, pain during intercourse and morphological changes lead to discomfort and embarrassment.

To maintain Intimate well-being and enhance intimacy, Neauvia developed NROSE a WOMEN INTIMATE REJUVENATION SYNERGISTIC PROTOCOL combining Intimate HA Filler, Radio Frequency and Aesthetic Cosmeceuticals.

Discover Nrose

PRODUCTS USED in SCT protocols

Neauvia Smart Combination Therapy Protocols are based on the in-house product portfolio of FILLERS, ENERGY BASED DEVICES AND AESTHETIC COSMECEUTICALS designed to work synergistically.

discover OUR BROCHURES

Explore our full range of brochures with just one click! To learn more about our products, view all of our detailed catalogs.

Simply click the button below to access all the information you need.

SEE ALL THE BROCHURES

If you are a professional, click here to discover more about our award-winning product “Stimulate” and explore techniques and feedback from industry peers on Neauviachannel.com, the first 24/7 aesthetic medicine channel.
Get free access to online scientific on-demand videos, training, expert talks, interviews and online events.

Discover more

Intense, Intense Man, Intense LV, Intense Lips, Intense Flux, Intense Rheology, Stimulate, Stimulate Man, Hydro Deluxe and Hydro Deluxe Man are class III medical devices regulated under the EU MDR 2017/745 Regulation. Intense Rose is a class III medical device regulated under the EU MDD 93/42 Directive.
Manufacturer: MATEX LAB SPA, via Carlo Urbani 2 ang. via Enrico Fermi, Brindisi, Italy.
Please carefully read the instructions in the leaflets. The use of these products requires the intervention of a healthcare professional.
Only to be used by physicians in accordance with local legislation, trained in the injection techniques on Hyaluronic Acid based fillers.

Zaffiro is a IIa class Medical Device, Sectum, Plasma IQ, EpliMe and LaserMe are IIb class Medical Device regulated health products which bear, under this regulation MDD 93/42, the CE mark. Manufacturer: B&K, Domaniewska 37, Warsaw, Poland. Please carefully read the instructions in the leaflets. The use of this product requires the intervention of a healthcare professional.

Neauvia Cosmeceuticals are cosmetic products according to EU Regulation 1223/2009.

1. Kubik et al., HA PEGylated Filler in Association with an Infrared Energy Device for the Treatment of Facial Skin Aging: 150 Day Follow-Up Data Report, Pharmaceuticals 2022, 15, 1355, DOI: 10.3390/ph15111355.
2. Kolczewski et al., Hyaluronic Acid and Radiofrequency in Patients with Urogenital Atrophy and Vaginal Laxity, Pharmaceuticals 2022, 15, 1571, DOI: 10.3390/ph15121571
3. Cotofana, S.; Fratila, A.A.; Schenck, T.L.; Redka-Swoboda,W.; Zilinsky, I.; Pavicic, T. The Anatomy of the Aging Face: A Review.Facial Plast. Surg. 2016, 32, 253–260. DOI: 10.1055/s-0036-1582234
4. Chen, J.; Liu, Y.; Zhao, Z.; Qiu, J. Oxidative stress in the skin: Impact and related protection. Int. J. Cosmet. Sci. 2021, 43, 495–509. DOI: 10.1111/ics.12728
5. Blanpain C, Fuchs E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol. 2009 Mar;10(3):207-17. DOI: 10.1038/nrm2636. Epub 2009 Feb 11. PMID: 19209183; PMCID: PMC2760218.
6. Nguyen AV, Soulika AM. The Dynamics of the Skin’s Immune System. Int J Mol Sci. 2019;20(8):1811. Published 2019 Apr 12. DOI:10.3390/ijms20081811
7. Eleanor Russell-Goldman, George F. Murphy, The Pathobiology of Skin Aging: New Insights into an Old Dilemma, The American Journal of Pathology, Volume 190, Issue 7, 2020, Pages 1356-1369.
8. Brenner M, Hearing VJ. The protective role of melanin against UV damage in human skin. Photochem Photobiol. 2008;84(3):539-549. DOI:10.1111/j.1751-1097.2007.00226.